Privacy-preserving AI tool for classifying coronary syndromes
Part of Heart & circulation, Pain clinical trials.
This trial tests an AI system that reads your admission notes to help doctors classify heart conditions like heart attacks and chest pain into specific types. It aims to improve accuracy and privacy in diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been admitted to a hospital with symptoms related to coronary syndrome (heart-related chest pain or heart attack).
- Your admission notes contain enough information to determine which of the four heart condition types you have.
- Your admission notes are clear about the timing of your symptoms.
- Your primary reason for admission is related to coronary heart disease, not another condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses machine learning (a type of artificial intelligence) to help doctors diagnose acute heart or vessel conditions faster. It may lead to quicker treatment for patients with sudden heart problems.
This study is testing a new AI tool that helps doctors understand and treat coronary artery disease. If you have or might have this condition, your medical information could help improve the tool for future patients.
This trial tests an artificial intelligence system that helps doctors quickly identify heart attacks (myocardial infarction) in patients with symptoms like chest pain or shortness of breath. It aims to speed up diagnosis and treatment.
This trial uses artificial intelligence to analyze ECG results and timing in patients with a type of heart attack called Non-STEMI (where the artery is narrowed but not fully blocked). The goal is to see if AI can help predict damage and outcomes, which could lead to better care.
This trial uses an artificial intelligence (AI) tool to analyze heart CT scans (CCTA) and identify dangerous plaque buildup that could lead to a heart attack. It aims to see if AI can better predict high-risk plaques in people with known or suspected coronary artery disease (CAD).
This study tests whether artificial intelligence (AI) programs can accurately calculate a chest pain risk score to help doctors decide who needs urgent heart tests. You'll be monitored for 30 days to see if the AI's predictions were correct.
Hear when a new ST-segment Elevation Myocardial Infarction (STEMI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.